ADAR and neoplasm: A-to-I RNA editing contributes to proteomic diversity in breast cancer through changes in amino acid sequences (Peng et al., 2018) and are increased in most tumor tissues examined, which may be associated with ADAR1 overexpression (Xu et al., 2018; Fritzell et al., 2019).